Handelsavisen
prelaunch
Companies Healthcare WPH.BK
WP
WPH.BK SET (Bangkok) Healthcare Facilities & Services

Wph.Bk

$6,00
Open in Charts → Attach watcher ⌖
THB
Set alert
Last 30 days
1D5D1M3M6MYTD1Y5YMax
Live price chart loads from the market-data widget.
Mcap
4,3B THB
P/E
EV / Rev
Div yield
1,27 %
Op margin
19,7 %
ROE
18,2 %
Net margin
15,1 %
Debt / equity
0,64
Beta
52w range
Volume
Day range
Prev close
Open
Next earnings
Ex-dividend
TR 1Y
About

WPH.BK operates in the healthcare sector, primarily engaged in pharmaceuticals and healthcare facilities and services, generating revenue through the provision of healthcare-related products and services.

Business. WPH.BK operates in the healthcare sector, primarily engaged in pharmaceuticals and healthcare facilities and services, generating revenue through the provision of healthcare-related products and services.

Classification92 %
SectorHealthcare
Business sectorHealthcare Services & Equipment
IndustryHealthcare Facilities & Services
ActivityPharmaceuticals
Generated · model-assisted
Sell-side consensus
consensus pending
— buy— hold— sell
Avg 12m price target
Upcoming events
— missing data
See all catalysts →

At a glance

Score
not yet scored
Valuation
valuation pending
Analysts
not yet wired
Ownership
not yet wired
Profitability
18,2 %
return on equity
Quality
not yet scored

What drives this business

The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.

— missing data

News & coverage

0
  • No recent newsroom coverage mentioning WPH.
  • Sector rotation

    Sector1D1Mvs mkt
    Materials+2,3 %+6,6 %+1,7 %
    Communication Services+2,2 %−5,5 %+1,6 %
    Energy+0,6 %+3,3 %+0,0 %
    Health Care · THIS SECTOR+0,6 %−0,8 %+0,0 %
    Information Technology+0,6 %+6,7 %+0,0 %
    Consumer Discretionary+0,4 %+7,6 %−0,2 %
    Financials−0,3 %−2,8 %−0,9 %
    Consumer Staples−0,4 %+2,5 %−1,0 %
    Real Estate−0,7 %+10,9 %−1,3 %
    Industrials−1,9 %−3,1 %−2,5 %
    Utilities−1,9 %+28,2 %−2,5 %

    Developing storylines

    No tracked sagas currently linked to WPH.BK. Browse all sagas →

    Analysis

    AI analysis
    Generated · analysis pipeline · tier hybrid · as of 2026-08-04 ↑ At a glance

    Opportunity

    — missing data

    Upcoming catalysts

    Scheduled public events. Informational only — not investment advice.

    • Macro
    • Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
    • Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
    • Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
    • Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
    • Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
    • Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
    • Macro & political
    • ElectionSE Swedish Election2026-09-14 · SE
    • ElectionUS U.S. Midterms2026-11-03 · US
    • ElectionFR French Legislative2027-06-01 · FR

    Pre-earnings brief

    — missing data

    Signals & dispatch

    peak dispatch · —

    Composite-score breakdown

    Synthesis

    Business

    WPH.BK operates in the healthcare sector, primarily engaged in pharmaceuticals and healthcare facilities and services, generating revenue through the provision of healthcare-related products and services.

    Classification92 %
    SectorHealthcare
    Business sectorHealthcare Services & Equipment
    IndustryHealthcare Facilities & Services
    ActivityPharmaceuticals
    AI synthesis
    GENERATED

    WPH.BK has a market price of 5.95 THB, with a market capitalization of 4,249,052,454.85 THB, indicating a moderate valuation. The company's price-to-earnings ratio is 12.08, and its price-to-book ratio is 2.2, suggesting that the stock is trading at a premium to its book value. The company's liquidity is rated as medium, with a current ratio of 0.97, indicating that it has nearly equal current assets to current liabilities.

    In terms of profitability, WPH.BK has a return on equity of 18.25% and a return on assets of 9.82%, which are strong indicators of efficient use of equity and assets. The company's operating income of 459,498,610 THB and net income of 351,755,410 THB reflect a healthy profit margin. The gross profit of 769,593,870 THB further supports the company's strong profitability.

    WPH.BK's revenue is concentrated in the healthcare sector, with no specific segment breakdown provided. The company's geographic exposure is not detailed, but its operations are primarily within the healthcare services and pharmaceuticals domain. The company's revenue of 2,329,850,480 THB is a significant figure, but the lack of segment details limits a more granular analysis.

    The company's growth trajectory is not explicitly detailed, but the free cash flow of -337,334,090 THB and capital expenditure of -861,075,640 THB suggest that WPH.BK is investing heavily in its operations. The operating cash flow of 535,185,860 THB indicates that the company is generating positive cash from its operations. The debt-to-equity ratio of 0.64 suggests a moderate level of leverage.

    The risk assessment for WPH.BK indicates a medium liquidity risk and a low dilution risk. The company's net cash is negative after subtracting total debt, which is a key flag to monitor. The dilution potential is low, and no significant adjustments have been applied to the valuation metrics.

    Recent events and filings for WPH.BK are not detailed in the provided data. The company's financial performance and risk profile are based on the latest available financial data.

    Key takeaways
    • WPH.BK has a strong return on equity of 18.25%, indicating efficient use of equity.
    • The company's price-to-book ratio of 2.2 suggests it is trading at a premium to its book value.
    • WPH.BK has a moderate level of leverage with a debt-to-equity ratio of 0.64.
    • The company's liquidity is rated as medium, with a current ratio of 0.97.
    • WPH.BK is investing heavily in its operations, as indicated by the capital expenditure of -861,075,640 THB.
    • margin_outlook_rationale: The company's strong gross and operating margins suggest a positive outlook for maintaining profitability.
    • rd_outlook_rationale: No specific R&D data is provided, but the company's investment in operations may include R&D activities.

    Bull / Bear case

    analysis pipeline
    — missing data

    In focus — financials by report

    Valuation

    Market price
    $6,00
    Market cap
    $4.25B
    Enterprise value
    $5.35B
    P/E
    Non-GAAP P/E
    EV / Revenue
    EV / Op income
    EV / OCF
    10.0x
    P / B
    2.2x
    P / Tangible book
    2.2x
    Tangible book
    $1.93B
    Net cash
    -$1.10B
    Current ratio
    1.0
    Debt / equity
    0.6
    ROA
    9.8%
    ROE
    18.2%
    Cash conversion
    152.0%
    CapEx / revenue
    -37.0%
    SBC / revenue
    Dilution ratio
    0.0%

    Revenue by segment

    Market share

    — missing data

    Business relationships

    — missing data

    Supply chain

    — missing data

    Peer comparison

    — missing data

    Market position

    Stress test

    — missing data

    Predictor forecast

    Options

    — missing data

    Short squeeze

    — missing data

    Earnings-call key lines

    — missing data

    Estimate revisions

    consensus EPS · 26-week trend
    — missing data

    Sell-side observations

    — missing data

    Themes

    — missing data

    ESG

    — missing data

    Risk factors

    Dilution riskLow
    Liquidity riskMedium
    Filing-based flags
    • Net cash is negative after subtracting total debt.

    Benchmarks vs cohort

    Op Margin19,7 %Above P75
    Net Margin15,1 %Above P75
    ROE18,2 %Above P75
    Capex / Rev-37,0 %Bottom quartile
    D/E0,64Below median
    Cash Conv1,52Above median

    Corporate actions / M&A

    — missing data

    FX exposure

    — missing data

    Comparable transactions

    — missing data

    Derivatives & instruments

    — missing data

    Actions

    Ask Handelsavisen

    — missing data
    Data sources
    • Market data
    • Market data cache
    • Issuer disclosures
    • Public news
    • Earnings transcripts
    • Consensus estimates
    • ESG data
    How metrics are computed
    • Ev To Operating Cash Flow
      enterprise_value / operating_cash_flow
    • Return On Equity
      net_income / total_equity
    • Price To Earnings
      market_price / (net_income / shares_outstanding_diluted)
    • Price To Book
      market_price / (adjusted_book_value / shares_outstanding_diluted)
    • Dilution Ratio
      (shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
    • Market Price
      input from market-data provider (delayed close or quote-shim mid)
    Source documents
    • WPH.BK Market data — financials · 2026-05-30

    Ownership & reference

    Insider activity

    — missing data

    Short positioning

    — missing data

    Geographic breakdown

    — missing data
    Listings · one canonical issuer all listings resolve to the canonical
    WPH.BKCanonical
    SET (Bangkok) · THB

    Intel & risk

    peak dispatch · —
    OSINT findings
    Dilution riskLow
    Liquidity riskMedium
    Net cash is negative after subtracting total debt.

    Evidence & claims

    From filings & derived data
    — missing data

    The Thread

    Everything we know, in order
    — missing data
    Sources filings · IR · transcripts · market data · tier hybrid · as of 2026-08-04 Market data · Issuer disclosures · Public news · Earnings transcripts · Consensus estimates · ESG data Premium coverage